Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
7.13
-0.05 (-0.70%)
At close: Aug 26, 2026, 4:00 PM EDT
7.13
0.00 (0.00%)
After-hours: Aug 26, 2026, 4:10 PM EDT
Upstream Bio Employees
Upstream Bio had 75 employees as of December 31, 2025. The number of employees increased by 23 or 44.23% compared to the previous year.
Employees
75
Change (1Y)
23
Growth (1Y)
44.23%
Revenue / Employee
$42,107
Profits / Employee
-$2,086,667
Market Cap
390.52M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 75 | 23 | 44.23% |
| Dec 31, 2024 | 52 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Rocket Pharmaceuticals | 202 |
| Enanta Pharmaceuticals | 120 |
| Foghorn Therapeutics | 106 |
| Zentalis Pharmaceuticals | 106 |
| Agenus | 81 |
| Century Therapeutics | 78 |
| Lexeo Therapeutics | 63 |
| X4 Pharmaceuticals | 45 |
UPB News
- 9 days ago - Upstream Bio price target lowered to $25 from $43 at Truist - TheFly
- 10 days ago - Upstream Bio price target raised to $9 from $8 at JPMorgan - TheFly
- 15 days ago - Upstream Bio price target lowered to $25 from $43 at Truist - TheFly
- 15 days ago - Upstream Bio reports Q2 revenue $773,000, consensus $377,250 - TheFly
- 15 days ago - Upstream Bio Earnings release: Q2 2026 - Filings
- 15 days ago - Upstream Bio Quarterly report: Q2 2026 - Filings
- 15 days ago - Upstream Bio Slides: Corporate presentation - Filings
- 2 months ago - Upstream Bio management to meet with Piper Sandler - TheFly